公司資料
Revelation Biosciences 股價、新聞與催化劑
- 股票代碼:
- REVB
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股票表現
1.15 USD (+9.63%)
收盤價
最後更新: 2026年8月17日
4.14M USD
市值
股價為何變動
As of Aug 17, 2026, REVB closed up 9.63% at $1.15. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Revelation Biosciences is a biotechnology company focused on innate immunity and inflammation-linked disease biology. Its story centers on using immune modulation to address difficult inflammatory conditions.
所在地與產業分類
Revelation is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology with an immunology focus.
商業模式特徵
The company depends on early clinical and preclinical progress, capital efficiency, and the ability to show that its platform can create differentiated value. Investors watch proof-of-concept data and financing runway.
生技產業定位
Revelation occupies a speculative immune-modulation niche within biotech. It is a small company where data quality and strategic focus dominate the stock.
未來催化劑
- Revelation’s catalysts are microbiome / inflammation programs and any update that shows the platform can still progress clinically. The company remains highly dependent on data.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。